This scoping review evaluates recent advancements in data-driven technologies for predicting non-neonatal pediatric sepsis, including artificial intelligence, machine learning, and other methodologies. Of the 27 included studies, 23 (85%) were single-center investigations, and 16…
Continue Reading
In this work we present OptAB, the first completely data-driven online-updateable antibiotic selection model based on Artificial Intelligence for Sepsis patients accounting for side-effects. OptAB performs an iterative optimal antibiotic selection for real-world Sepsis…
Continue Reading
Dr. Francesco Pompei, CEO and Founder of Exergen Corporation
Accurate and frequent temperature monitoring is paramount when it comes to ensuring favorable patient outcomes in the medical community. When a patient is admitted to the…
Continue Reading
South Korean medical AI company AITRICS has obtained clearance from the Ministry of Health, Vietnam for its AI software for predicting patient deterioration.VitalCare utilises AI to analyse 19 types of EMR data of patients…
Continue Reading
What You Should Know:
– Cytovale, a medical diagnostics company revolutionizing early disease detection secures $100M in Series D funding round led by Sands Capital with participation from new investor Canada Pension Plan Investment Board…
Continue Reading
“Sepsis is more deadly than heart attack and stroke combined — in fact it’s the deadliest, costliest, and arguably most complex condition facing hospitals today.”
Those remarks came from Ajay Shah, CEO of San Francisco-based…
Continue Reading
North Tees and Hartlepool NHS Foundation Trust has received accolades from NHS England following the success of its electronic observations (eObs) and sepsis dashboard.
The trust received the NHS Blueprint of the Month award in…
Amid doctors’ strikes, the Ministry of Health and Welfare in South Korea has announced a new project that will harness artificial intelligence in the development of a clinical decision support system for emergency departments.It is…
Continue Reading
Several innovators have created algorithms to predict and manage this life-threatening complication.
By John Halamka, M.D., President, Mayo Clinic Platform and Paul Cerrato, MA, senior research analyst and communications specialist, Mayo Clinic Platform
The statistics are…
Continue Reading
This week, Prenosis gained FDA clearance for its sepsis detection technology — marking the first time the agency has cleared an AI diagnostic tool for sepsis.
Chicago-based Prenosis was founded in 2014 with “a mission…
Continue Reading
